Vanda Pharmaceuticals (VNDA) Tax Provisions (2010 - 2026)

Vanda Pharmaceuticals has disclosed Tax Provisions across 12 years of filings, most recently posting $100000.0 for Q1 2026.

• Tax Provisions for Q1 2026 came in at $100000.0, up 101.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $89.8 million (up 888.44% YoY), and the FY2025 annual result was $81.8 million, up 2134.99% from the prior year.
• Tax Provisions came in at $100000.0 for Q1 2026 at Vanda Pharmaceuticals, down from $103.2 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $103.2 million in Q4 2025 to a low of -$7.9 million in Q1 2025.
• The 5-year median for Tax Provisions is -$257000.0 (2023), against an average of $5.1 million.
• Peak annual rise in Tax Provisions reached 6468.11% in 2025, while the deepest fall reached 1474.8% in 2025.
• Vanda Pharmaceuticals' Tax Provisions stood at $2.8 million in 2022, then sank by 73.47% to $730000.0 in 2023, then slumped by 322.05% to -$1.6 million in 2024, then jumped by 6468.11% to $103.2 million in 2025, then tumbled by 99.9% to $100000.0 in 2026.
• The last three Tax Provisions figures came in at $100000.0 (Q1 2026), $103.2 million (Q4 2025), and -$5.8 million (Q3 2025), per Business Quant data.